Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01040897 · ClinicalTrials.gov registry record · NA

Addressing Health Literacy and Numeracy to Prevent Childhood Obesity

A NA study, sponsored by Vanderbilt University.

Completed
Registry status
NA
Development phase
865
Enrollment target

NCT01040897: Completed NA study, sponsored by Vanderbilt University.

NCT01040897 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 865 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01040897, a NA study, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
NA
Development phase
865 participants
Enrollment target

Study Summary

In 2003, Surgeon General Richard Carmona suggested that low health literacy is "one of the largest contributors to our nation's epidemic of overweight and obesity." Over 26% of preschool children are now overweight or obese, and children who are overweight by age 24 months are five times as likely as non-overweight children to become overweight adolescents. The aim of the study is to assess the efficacy of a low-literacy/numeracy-oriented intervention aimed at teaching pediatric resident physicians to promote healthy family lifestyles and prevent overweight among young children (age 0-2) and their families in under-resourced communities.

Interventions

  • BEHAVIORAL Health Communication and Obesity Prevention
  • BEHAVIORAL Injury Prevention Arm

Trial Details

FieldValue
Enrollment Target 865 participants
Start Date 2010-04-28
Est. Completion 2014-10-01
Phase NA
Vanderbilt University

430 total trials

What the finished NCT01040897 record still lists

NCT01040897 is an interventional study that assigns participants to a tested intervention. The registered 865 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower).

The record links to 0 conditions, and to 2 interventions - of which Health Communication and Obesity Prevention is the first listed.

NCT01040897 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01040897 about?

NCT01040897 is a clinical study titled "Addressing Health Literacy and Numeracy to Prevent Childhood Obesity". In 2003, Surgeon General Richard Carmona suggested that low health literacy is "one of the largest contributors to our nation's epidemic of overweight and obesity." Over 26% of preschool children are now overweight or obese, and children who are overweight by age 24 months are five times as likely a...

What is the current status of trial NCT01040897?

This trial is currently completed. It is a NA study. The enrollment target is 865 participants. The study started on 2010-04-28. Estimated completion is 2014-10-01.

What interventions are being tested in trial NCT01040897?

The interventions under investigation include: Health Communication and Obesity Prevention (BEHAVIORAL), Injury Prevention Arm (BEHAVIORAL).

Who is sponsoring clinical trial NCT01040897?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01040897's enrollment target sits among peer trials

865 130th of 2000 higher than 1,871 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05369052 · 865 participants · Phase 3

    Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)

  • NCT06256588 · 864 participants · Phase 3

    A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

  • NCT06527794 · 864 participants · NA

    Remote Hypertension Management for Black Patients

  • NCT04933552 · 867 participants

    Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01040897, the US trial registry maintained by the National Library of Medicine. NCT01040897 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.